… the effect of erlotinib-plus-bevacizumab combination compared to erlotinib monotherapy. It
is … effect estimates for both subgroups favored the erlotinib-plus-bevacizumab combination. …

… the combination of erlotinib plus bevacizumab vs erlotinib … erlotinib plus bevacizumab
with erlotinib monotherapy in … in PFS with bevacizumab and erlotinib did not translate into an …

… However, the efficacy of bevacizumab in combination with erlotinib remains … compare
combination treatment with bevacizumab and erlotinib to bevacizumab or erlotinib monotherapy in …

… Our meta-analysis indicates that compared with monotherapy, erlotinib+bevacizumab
combination therapy prolongs PFS of patients with NSCLC, but cannot extend OS or elevate ORR. …

… The combined strategy showed promising benefits to … suggest that erlotinib in combination
with bevacizumab could be … merits of erlotinib plus bevacizumab over monotherapy in EGFR- …

… group compared with the erlotinib monotherapy group (16·0 months [95% CI 13·9–18·1] vs
9·… to compare erlotinib plus bevacizumab combination therapy with erlotinib monotherapy for …

… was seen with erlotinib or bevacizumab monotherapy, a decreased invasive potential on …
We present novel data on the efficacy of a combination of erlotinib and bevacizumab in …

… is a possible resistance marker to erlotinib monotherapy, 17 best … combination of erlotinib
and bevacizumab may be active in a broader population of patients compared with erlotinib …

… erlotinib and gefitinib (Iressa; Astra-Zeneca) as monotherapy in … Phase II trials of bevacizumab
plus erlotinib have reported … to evaluate the combination of erlotinib and bevacizumab as …

… We conducted a phase I study combining erlotinib, cetuximab, and bevacizumab. Patients
… Resistance to BRAF V600E in BRAF monotherapy was overcome by combining BRAF and …